Get Live Data
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Hemogenyx Pharmaceuticals Share Price
  4. Hemogenyx Pharmaceuticals Share Regulatory News
  5. Suspension

Pin to quick picksHemogenyx Pharmaceuticals Regulatory News (HEMO)

Hemogenyx Pharmaceuticals Information

Share Price Information for Hemogenyx Pharmaceuticals (HEMO)

Share Price is delayed by 15 minutes
Get Live Data
724.00    -5.50 (-0.75%)
Bid:
725.00
Ask:
747.00
Spread: 22.00 (3.034%)
Market Cap: £49.23m
HEMO Live PriceLast checked at - London Stock Exchange

Intraday Hemogenyx Pharmaceuticals Share Chart

Suspension

23 Dec 2015 12:45

RNS Number : 0583K
Official List
23 December 2015
 

NOTICE OF TEMPORARY SUSPENSION OF LISTING FROM THE OFFICIAL LIST

 

 

 

23/12/2015 12:45 PM

 

TEMPORARY SUSPENSION

 

Silver Falcon Plc

 

The Financial Conduct Authority ("the FCA") temporarily suspends the securities set out below from the Official List effective from 23/12/2015 12:45 PM at the request of the company pending an announcement:

 

Ordinary shares of GBP0.01 each

fully paid.

Standard Shares

(GB00BYX3WZ24) 

 

 

 

This notice has been issued by Listing Applications - 0207 066 8352.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NOTFEIFEDFISEDE
12345678910
Date   Source Headline
29th May 20269:18 amRNSGrant of Options and Extension of Warrant Term
30th Apr 20264:04 pmRNSFinal Results
28th Apr 20267:00 amRNSInstitutional Fundraise
14th Apr 20267:00 amRNSAnnual IND Report with FDA
31st Mar 20261:22 pmRNSTech Transfer Completion and Clinical Trial Update
27th Feb 20268:10 amRNSTotal Voting Rights
24th Feb 20267:00 amRNSHolding(s) in Company
23rd Feb 20267:00 amRNSExercise of Warrants and Issue of Equity
10th Feb 20263:52 pmRNSIssue of Equity - Correction
10th Feb 20267:00 amRNSIssue of Equity
30th Jan 20267:00 amRNSTotal Voting Rights
12th Jan 20267:00 amRNSHolding(s) in Company
22nd Dec 20258:00 amRNSUpdate on Admission of Shares
18th Dec 20257:00 amRNSIssue of Equity
8th Dec 202512:48 pmRNSHolding(s) in Company
28th Nov 20257:00 amRNSTotal Voting Rights
19th Nov 202511:47 amRNSPublication of Prospectus
29th Oct 20257:00 amRNSClinical Trial Update and Grant of Share Awards
6th Oct 20257:00 amRNSClearance to Initiate Pediatric Enrolment
30th Sep 20257:00 amRNSHalf-year Report
30th Sep 20257:00 amRNSTotal Voting Rights
23rd Sep 20257:00 amRNSHemogenyx Signs Letter of Intent
18th Sep 20251:16 pmRNSHolding(s) in Company
17th Sep 20257:00 amRNSThird Patient Safety
11th Sep 20257:00 amRNS-RInvitation to Participate at DCNY Summit
8th Sep 20257:00 amRNSManufacturing Partnership with Made Scientific
5th Sep 20257:00 amRNSExercise of Warrants and Issue of Equity
3rd Sep 20251:57 pmRNSExercise of Warrants and Issue of Equity
1st Sep 20253:06 pmRNSIssue of convertible loan notes
29th Aug 20257:00 amRNSResult of Audit Tender
26th Aug 202511:44 amRNSHemogenyx raises £570,000 and Director's Dealing
15th Aug 20257:00 amRNSThird Patient Treated with HG-CT-1 CAR-T Therapy
31st Jul 20257:00 amRNSTotal Voting Rights
29th Jul 20258:00 amRNSPlacing to Raise £250,000 and Director’s Dealing
16th Jul 20257:00 amRNSHemogenyx Awarded Grant
30th Jun 20257:00 amRNSTotal Voting Rights
17th Jun 20257:00 amRNSClearance to Proceed with Pediatric Expansion
3rd Jun 20252:02 pmRNSPlacing to Raise £451,250 and Director’s Dealing
3rd Jun 20257:00 amRNSSecond Patient Passes Initial Safety Tests
30th May 20253:14 pmRNSTotal Voting Rights
29th May 20252:06 pmRNSResult of AGM
14th May 20257:00 amRNS-RPediatric Amendment to Clinical Protocol
13th May 20257:00 amRNSAGM Correction
8th May 20257:00 amRNSPlacing to Raise £451,250 and Director’s Dealing
2nd May 20254:24 pmRNSNotice of AGM
2nd May 20257:00 amRNSSecond Patient Treated with HG-CT-1 CAR-T Therapy
28th Apr 20257:00 amRNSFinal Results
3rd Apr 20257:00 amRNS-RFDA Annual Report
31st Mar 20257:00 amRNSTotal Voting Rights
24th Mar 20257:00 amRNSFirst Patient Safety
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
NEP
Neptune-Calculus Income & Growth
LSE
0.00%
MTC
Mothercare
LSE
1.52%
TTG
Tt Electronics
LSE
-0.34%
POW
Power Metal Resources PLC
LSE
4.67%
ALL
Atlantic Lithium
LSE
-1.20%
Trending
GGP
Greatland Resources
LSE
-0.42%
SOLG
SolGold
LSE
0.00%
MPL
Mercantile Ports & Logistics
LSE
3.33%
CAML
Central Asia Metals
LSE
-6.46%
GKP
Gulf Keystone Petroleum
LSE
6.92%